ADC Therapeutics SA (ADCT) Stock Overview
NYSE · Healthcare · Drug Manufacturers - Specialty & Generic
✓ Sourced directly from Yahoo Finance · Checked for accuracy at every rebuild · Snapshot: 6 September 2026
About ADC Therapeutics SA
ADC Therapeutics SA provides antibody drug conjugate (ADC) technology platform in Switzerland and the United States. Its flagship product includes ZYNLONTA, a CD19-directed ADC, received accelerated approval from the U.S. Food and Drug Administration, conditional approval from the European…
Source: Yahoo Finance
Sector & Industry
ADC Therapeutics SA operates in the Healthcare sector, within the Drug Manufacturers - Specialty & Generic industry group. It is listed on the NYSE exchange.
ADC Therapeutics SA at a Glance
| Company | ADC Therapeutics SA |
| Ticker | ADCT |
| Exchange | NYSE |
| Currency | USD |
| Price | $1.36 |
| Market cap | $173.63M |
| P/E ratio (trailing) | — |
| EPS (trailing) | -$0.58 |
| 52-week high | $4.98 |
| 52-week low | $0.78 |
| Dividend yield | — |
| Ex-dividend date | — |
| Beta | 1.85 |
| Return on equity (ROE) | — |
| Debt-to-equity | — |
| Average volume | 1.78M |
| Shares outstanding | 127.67M |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Employees | 188 |
| Country | Switzerland |
Investing Essentials
As an Amazon Associate we earn from qualifying purchases. Links below are affiliate links.
Evaluating pharma pipelines, devices and healthcare economics.
Check Price →Benjamin Graham's classic on value investing — the book Warren Buffett calls the best ever written on the subject.
Check Price →Peter Lynch on how everyday investors can spot winners before the professionals do.
Check Price →Frequently Asked Questions
- What is ADC Therapeutics SA's current P/E ratio?
- ADC Therapeutics SA (ADCT) has a trailing P/E ratio of — as of our 6 September 2026 data snapshot. Learn what the P/E ratio means →
- What is ADC Therapeutics SA's market capitalisation?
- ADC Therapeutics SA's market cap is $173.63M based on our latest snapshot. See how it ranks by market cap →
- What is ADCT's 52-week range?
- Over the past 52 weeks, ADCT has traded between $0.78 and $4.98. What does the 52-week range mean? →
- How volatile is ADC Therapeutics SA compared to the market?
- ADC Therapeutics SA has a beta of 1.85, meaning it has historically moved more than the broader market. What does beta measure? →
- Does ADC Therapeutics SA pay a dividend?
- ADC Therapeutics SA does not currently pay a dividend according to our latest data.
- What exchange is ADCT listed on?
- ADCT is listed on the NYSE. Browse all NYSE-listed stocks →
- What sector is ADC Therapeutics SA in?
- ADC Therapeutics SA is classified in the Healthcare sector. Compare with Healthcare peers →
Prefer raw numbers at a glance? Browse our size and reference charts for quick lookups.
Many readers keep a stock investing journal to log positions and theses alongside pages like this one, and a dedicated financial calculator to hand for quick valuation maths.
Recommended Reading & Tools
Philip Fisher on what makes a business worth owning for the long term.
Check Price →Morgan Housel's short lessons on behaviour, luck and long-term wealth.
Check Price →Burton Malkiel's evidence-based guide to markets, indexing and long-term strategy.
Check Price →